naphthol level significantly correlated with the 8-OHdG level only in subjects with the GSTM1 null-type. In conclusion, there is a significant correlation between the 8-OHdG level in leukocytes and the urinary 1-OHP concentration in the population not occupationally exposed to PAHs. This relationship is affected by genetic polymorphisms in PAH metabolic enzymes. (J Occup Health 2003; 45: 160-167) Key words: 8-hydroxydeoxyguanosine, 1-hydroxypyrene, 2-naphthol, Metabolic enzyme, Polymorphism
Reactive-oxygen species (ROS) are produced by environmental agents such as radiation and chemical carcinogens, as well as by endogenous oxygen metabolism [1] [2] [3] . ROS can cause extensive DNA damage, including single-strand breaks and the formation of modified bases such as 8-hydroxydeoxyguanosine (8-OHdG) 4) . The level of 8-OHdG has been used as a marker for the evaluation of DNA damage caused by oxidative stress 5) . Polycyclic aromatic hydrocarbons (PAHs), which are formed during incomplete combustion of fossil fuels, are widely distributed in our environment 6) . Human exposure to PAHs may occur through smoking, polluted air, food consumption and occupational contact [7] [8] [9] . Urinary 1-hydroxypyrene (1-OHP) and 2-naphthol concentrations are used as biomarkers for exposure to PAHs [10] [11] [12] . The latter has been reported to be a good marker for nonoccupational inhalation exposure to PAHs 12) . Previous reports have demonstrated that neonatal urinary 8-OHdG concentrations are significantly associated with maternal exposure to environmental tobacco smoke 13) , and that 8-OHdG levels are high in the lung tissue of individuals exposed to diesel exhaust particles 14) . This led to speculation that PAHs could induce ROS formation in the human body. If this were the case, the 8-OHdG level would show a positive correlation with urinary concentrations of PAH metabolites. This relationship would be influenced by the genetic polymorphisms of CYP1A1 15) , CYP2E1 16) , GSTM1 16, 17) , NAT2 17) and UGT1A6 18) , which have been reported to be involved in the metabolism of PAHs.
In this study, we evaluated the relationship between environmental PAH exposure and oxidative stress, the effects of a smoking habit and the genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, NAT2 and UGT1A6 on the relationship.
Materials and Methods

Study subjects
This study was conducted in accordance with the recommendations outlined in the Declaration of Helsinki. One hundred and five healthy Korean males were enrolled in this study. After having given their written informed consent, they were asked to fill out a standardized questionnaire about demographic factors and their smoking habit. Whole blood and spot urine specimens were collected from each subject and kept at -20°C until analyzed.
Analysis of urinary 1-hydroxypyrene and 2-naphthol
For the analysis of urinary 1-OHP and 2-naphthol concentrations, we used the methods developed by Jongeneelen et al. 10) and by Kim et al. 11) , respectively. In short, urine samples were buffered with sodium acetate buffer (pH 5.0), and hydrolyzed enzymatically by using β-glucuronidase with sulfatase activity (Sigma, St. Louis, MO) for 16 h at 37°C in a shaking water bath. After hydrolysis, acetonitrile was added and the samples were centrifuged at 10,000 g for 10 min. A high-performance liquid chromatography (HPLC) system, consisting of a pump (Waters 600E, Millipore, Milford, MA), variablefluorescence detector (RF-10AxL, Shimadzu, Kyoto, Japan), an automatic injector (L-7200, Hitachi, Tokyo, Japan), and an integrator (Chromatopac C-R3A, Shimadzu, Kyoto, Japan), was used. A 150 mm long reverse-phase column (TSK gel ODS-80 TM , Tosoh, Tokyo, Japan) was used for 1-OHP analysis, and a 250 mm long reverse-phase column (J'sphere ODS-H80, YMC, Wilmington, NC) for 2-naphthol analysis. The mobile phase was 58% (v/v) acetonitrile for 1-OHP, and 38% (v/v) acetonitrile for 2-naphthol. Excitation/emission wavelengths used in the detection of 1-OHP and 2-naphthol were 242/388 nm and 227/355 nm, respectively.
DNA isolation and 8-hydroxydeoxyguanosine measurement
An assay of the 8-OHdG level in leukocytes was performed by a method described by Kasai et al. 19) with a minor modification. Briefly, DNA was extracted from peripheral blood with a DNA Extractor WB kit (Wako, Osaka, Japan), digested with nuclease P1 (Sigma, St Louis, MO) and treated with alkaline phosphatase (Sigma, St Louis, MO) at 37°C for 1 h, and injected, after centrifugation, into the HPLC system. All these procedures were performed under dark conditions. The nucleosides were separated on a 0.46 × 25 cm reversephase column (Shodex C18-10B, Shoko, Japan) with 10 mM phosphate buffer containing 10% (v/v) methanol. The 8-OHdG level was determined with an electrochemical detector (Coulochem II Model 5200A, ESA, Chelmsford, MA) and deoxyguanosine (dG) was determined with a UV detector (Model 115, Gilson, France). The level of 8-OHdG was expressed as the number of 8-OHdG per 10 5 dG.
Determination of genotypes
The A4889G polymorphism in exon 7 of CYP1A1 that results in an Ile Val amino acid replacement at residue 462 was determined by the PCR-RFLP method described by Oyama et al. 20) Genotyping of the Rsa I polymorphism in the 5'-flanking region of CYP2E1 was carried out according to the method described by Kawamoto et al. 21) with a minor modification. The GSTM1 polymorphism was determined by the PCR procedure described by Comstock et al. 22) The genotype of NAT2 was identified by the method described by Deguchi 23) , and the phenotype was classified as either a rapid, intermediate or slow acetylator according to the genotype.
The UGT1A6 genotyping was performed as described b y C i o t t i e t a l . 2 4 ) A s e n s e p r i m e r [ 5 ' -CCCTCGAGGGAAATACCTAGGAGCCCTGTGA-3'] a n d a n a n t i -s e n s e p r i m e r [ 5 ' -AGGAGCCAAATGAGTGAGGGAG-3'] were used to amplify exon 1 of the UGT1A6 gene. The amplified product was digested with endonucleases BsmI and Fnu4HI to identify the A to G transition at codon 181 (T181A) and the A to C transversion at codon 184 (R184S) mutations. We classified the UGT1A6 genotype without any allele containing either T181A or R184S as the wild-type sequence, with other genotypes as the mutant forms.
Statistical analysis
The Student's t-test was used to compare the mean 8-OHdG levels of smokers and non-smokers, and of the different genotypes of CYP1A1, CYP2E1, GSTM1, NAT2 and UGT1A6, respectively. Pearson correlation coefficients of the 8-OHdG level with age, duration and amount of cigarette smoking, and urinary 1-OHP and 2-naphthol concentrations, were estimated. Correlations between the 8-OHdG level and urinary concentrations of the PAH metabolites were statistically tested with respect to smoking status and the genotypes of CYP1A1, CYP2E1, GSTM1, NAT2 and UGT1A6 genes, respectively. Finally, multiple regression analyses including the smoking status, the genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, NAT2 and UGT1A6, and the urinary concentration of 1-OHP or 2-naphthol as the independent variables were performed on 8-OHdG levels in leukocytes.
Results
The distributions of age, 8-OHdG levels and urinary 1-OHP and 2-naphthol concentrations are shown in Table  1 . When comparisons were made with respect to the smoking status, urinary 1-OHP and 2-naphthol concentrations were significantly higher in smokers than in non-smokers, but the 8-OHdG level was not.
The level of 8-OHdG in leukocytes significantly correlated with the urinary 1-OHP concentration in all subjects and in smokers, and with the urinary 2-naphthol concentration in non-smokers (Table 2) . Table 3 shows the distribution of the 8-OHdG level in smokers and in non-smokers according to the genetic polymorphisms of the five metabolic enzymes. The level of 8-OHdG was significantly higher in individuals with the UGT1A6 wild-type than those with the UGT1A6 mutant-type. Smoking rapid acetylators showed a higher 8-OHdG mean level than smoking slow or intermediate acetylators, but there is no enzyme that showed a significant difference in the 8-OHdG level according to the genetic polymorphism.
We tested the correlations between the 8-OHdG level, and urinary 1-OHP and 2-naphthol concentrations according to the genetic polymorphism of the five genes. We found significant correlations between the 8-OHdG level and urinary 1-OHP concentration in subjects with the GSTM1 null-type, the NAT2 rapid acetylator type and the UGT1A6 wild-type, respectively. A significant correlation between the 8-OHdG level and urinary 1-OHP concentration was found in every genotype of CYP1A1 and CYP2E1. On the other hand, the correlation between the 8-OHdG level and urinary 2-naphthol concentration was significant only in subjects with the GSTM1 nulltype (Table 4) .
In a multiple linear regression analysis including the smoking status and the genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, NAT2 and UGT1A6, and the urinary 1-OHP concentration as the independent variables, only the urinary 1-OHP concentration showed a significant association with the 8-OHdG level (Table  5 ), but there was no variable that showed a significant association with the 8-OHdG level in the multiple regression analysis that included the urinary 2-naphthol concentration as an independent variable instead of the urinary 1-OHP concentration (Table 6 ). 
Discussion
The level of 8-OHdG in leukocytes is significantly associated with cigarette smoking 25) , and maternal environmental tobacco smoking increases the urinary 8-OHdG level in neonates 13) . In the present study, the 8-OHdG level was not significantly correlated with variables related to cigarette smoking when considering all subjects, but correlated with the urinary 1-OHP concentration in smokers and with the total duration of smoking in rapid acetylators (data not shown). These facts suggest that PAHs in cigarette smoke could increase the 8-OHdG level in smokers, but it seems to be dependent on genetic polymorphisms in the metabolic enzymes.
The mechanism of ROS generation by PAHs is not fully understood yet, but Cu(I) plays an important role. The hydroxyl radical generated by a Cu(I)-catalyzed Fenton reaction is the primary species responsible for DNA fragmentation by o-quinones 26) . Ohnishi and Kawanishi 27) have reported that the reduction by NADH and auto-oxidation of benzo[a]pyrene-7,8-dione occurs concomitantly with the generation of superoxide anion, which is dismutated to hydrogen peroxide, and hydrogen peroxide in turn interacts with Cu(I) to form a DNAcopper-hydroperoxo complex, which causes DNA damage. CYP1A1 and CYP2E1 have been known as enzymes that can be induced by PAHs and ethanol, respectively, and their genetic polymorphisms have been reported to correlate with the metabolisms of various PAHs 16, 21) . In this study, the 8-OHdG level in leukocytes did not differ according to the genetic polymorphisms of CYP1A1 and CYP2E1. Moreover, the 8-OHdG level in leukocytes correlated with urinary 1-OHP in every polymorphic type of CYP1A1 and CYP2E1. Nevertheless, the correlation was stronger in subjects with the CYP2E1 c2/c2 or c1/c2 form (R=0.42, p-value < .01) than in those with the c1/ c1 form (R=0.29, p-value < .05). The correlation coefficient was also slightly larger in subjects with the CYP1A1 Ile/Val or Val/Val type (R=0.39, p-value < .05) than in those with the CYP1A1 Ile/Ile type (R=0.30, p- value < .05). In light of the fact that the CYP2E1 c2/c2 genotype is associated with the high activity of CYP2E1 enzyme 28) , and that aryl-hydrocarbon hydroxylase inducibility is higher in individuals with the CYP1A1 Val/ Val type than in those with the CYP1A1 Ile/Ile type 29) , these results suggest that ROS can be induced by the metabolism of PAHs by CYP2E1 or CYP1A1. Since the expression level of CYP2E1 is higher, but that of CYP1A1 is lower in Asians than in Caucasians 30) , and CYP2E1 rather than CYP1A1 is the major phase I enzyme metabolizing PAHs in Koreans 16) , CYP2E1 would be more important than CYP1A1 in the 8-OHdG generation by PAHs in Koreans.
The GSTs are phase II enzymes involved in the protection of cells against oxidative stress by electrophilic metabolites 31) . In this study, the correlations between the 8-OHdG level, and urinary concentration of 1-OHP and 2-naphthol were significant in subjects with the GSTM1 null-type, but not in those with the GSTM1 positive-type. These results are in agreement with previous reports that the presence of PAHs-dGMP adducts in human lung tissue was associated with the GSTM1 null-genotype 32, 33) , and that the urinary 2-naphthol concentration was higher in GSTM1 null subjects 16) . These facts lead to a suggestion that GSTM1 would play a critical role in the mechanism protecting against oxidative stress induced by PAHs 31) . The NAT2 enzyme has been known to detoxify carcinogenic aryl amines and PAHs 34) , but some previous studies have suggested that rapid acetylators are more susceptible to colorectal cancer due to the activation of dietary heterocyclic amines 35, 36) , and colorectal patients showed a higher frequency of the rapid acetylator genotype than controls 37) . A greater risk of bladder cancer has also been reported in Korean rapid acetylators 38) . In this study, rapid acetylators showed significant correlations between the 8-OHdG level in leukocytes and the urinary 1-OHP concentration. This suggests that Nacetylation of PAHs would increase ROS production.
Two missense-mutations on one allele of UGT1A6 result in the T181A and R184S amino acid substitutions and in reduced activity against phenolics, such as 4-nitrophenol, 4-hydroxycoumarin and butylated hydroxyanisole 24) . Nevertheless, the influence of the UGT1A6 polymorphisms on the metabolism of PAHs and their clinical significance are not yet fully understood. In the present study, in individuals with the UGT1A6 wildtype, the 8-OHdG level in leukocytes significantly correlated with the urinary 1-OHP concentration. These findings suggest the possibility that glucuronidation of PAHs by UGT1A6 converts the chemicals to metabolites, which can induce oxidative stress.
The level of the 8-OHdG was significantly higher in smoking rapid acetylators than in smoking slow or intermediate acetylators, and in individuals with the UGT1A6 wild-type than in those with the UGT1A6 mutant type. There were significant correlations between the 8-OHdG level and urinary 1-OHP level in NAT2 rapid acetylators, subjects with the UGT1A6 wild-type, and those with the GSTM1 null type. The effective clearance of PAH metabolites by NAT2 or UGT1A6 in the bodies of NAT2 rapid acetylators and subjects with the UGT1A6 wild-type would accelerate phase I reactions of PAHs which produce substrates for the NAT2 or UGT1A6 enzyme. If more ROS are formed by the phase I reactions which metabolize PAHs to the substrates for NAT2 or UGT1A6 than other phase I pathways, then the level of 8-OHdG could be increased in rapid acetylators and individuals with UGT1A6 wild-type. These indirect effects of phase II enzymes should be considered in the interpretation of the differences in the 8-OHdG level and in correlations between the 8-OHdG level and urinary 1-OHP level according to the genotype of NAT2 or UGT1A6.
In all subjects, and in particular those with any genotype of CYP1A1 or CYP2E1, the genotype of a rapid acetylator, or the UGT1A6 wild-type, the level of 8-OHdG in leukocytes correlated with urinary 1-OHP, but not with 2-naphthol. There is the possibility that more ROS is produced by high molecular weight PAHs than by smallsized ones. The fact that naphthalene is absorbed mainly through the respiratory tract leads to another possible explanation: that PAHs absorbed via the GI tract or the skin show signs of greater oxidative damage than those absorbed through the respiratory tract 39) . In conclusion, there is a significant correlation between the 8-OHdG level in leukocytes and the urinary 1-OHP concentration in the population not occupationally exposed to PAHs. This relationship is affected by genetic polymorphisms in PAH metabolic enzymes.
